GlassScriptPhysician profile
Marjorie Szeto
NPI 1245317254
$2,548.74
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,806 · 2020: $743.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,145.22 | 2019-2020 | |
| Therapeuticsmd, INC. | $394.46 | 2019-2020 | |
| Allergan, INC. | $242.95 | 2019-2020 | |
| Astellas Pharma US INC | $225.00 | 2019 | |
| Exeltis, USA INC. | $125.72 | 2019-2020 | |
| Tesaro, INC. | $115.78 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $109.32 | 2019 | |
| Coopersurgical, INC. | $100.00 | 2020 | |
| Amag Pharmaceuticals, INC. | $29.69 | 2019 | |
| Duchesnay USA Incorporated | $22.00 | 2019 | |
| Avion Pharmaceuticals | $14.69 | 2019 | |
| Covidien LP | $12.79 | 2019 | |
| Aspira Women'S Health INC | $11.12 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marjorie Szeto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.